The following frequently asked questions are intended to provide initial help in case of technical questions for some of our products. For more detailed information, please contact support@
Gastroenterology
Quantum Blue®
Cellular Allergy
Clinical Chemistry
Neuroimmunology
Gastroenterology – Stool extraction
Morning stool is preferred as it reflects best the current status of the intestine.
Nothing should ever be added to samples before extracting with any BÜHLMANN extraction devices.
CALEX® Cap: Add 10 µl liquid stool in CALEX® body and mix.
Smart-Prep (Roche): Add 80 µl of liquid stool sample in cup or prefilled tube and mix with 4 ml of B-CAL-EX.
Quick-Prep (ScheBo): Add 26 µl of liquid stool in Quick-Prep Tube (1.3 ml) and mix.
Collect stool from at least 3-5 different positions in order to completely fill the grooves of the dosing tip.
Prolong the incubation time and if possible vortex the sample from time to time.
Stool samples: at least 8 month at -20°C or at least 6 days at 2-8°C.
Extracts: at least 24 month at –20°C or at least 7 days at 2-8°C.
Gastroenterology – fCAL ELISA
No, the actual concentrations of the calibrators A-E are 4, 12, 40, 120 and 240 ng/ml. Therefore, the calibrators are ready to use in both, normal and extended range ELISA procedure.
No decrease of the optical density can be observed at concentrations higher than the saturation of the system. Therefore, no high dose hook effect could be observed.
Ensure for every washing a minimal incubation of at least 20 seconds. By using automated wash systems all strips must be filled before emptying begins in order to guarantee the minimal incubation time. Use “plate mode” in automated washer systems.
3 different (low, medium and high calprotectin) samples were tested 20 times. Mean, SD and % CV was calculated accordingly.
The inter-assay precision of the ELISA was calculated from 5 extracted stool samples. The aliquots were tested according to the assay procedure in 10 different runs by three technicians using 2 kit lots in two different labs.
Due to varying half-life time of NSAIDs, we recommend to stop the intake 1-2 weeks before the test.
Blood in stool samples does not interfere. Normally, the amount of blood in stool is rather low compared to the amount of calprotectin found in stool.
Gastroenterology – Quantum Blue®
The lot-specific calibrator is obtained from the RFID chip card. The Calprotectin concentrations of samples are directly calculated by the Quantum Blue® reader.
Yes, they can be ordered separately and contain a ready-to-use low and high control.
We highly recommend reading the test cassettes within 1 minute, since the reading process of Quantum Blue® is optimized for 1 minute.
For LF-CAL25 it is 1:1.6 for CALEX® Cap and 1:16 for Smart Prep and ScheBo.
For LF-CALE25 it is without further dilutions for CALEX® Cap and 1:10 for Smart Prep and ScheBo
For LF-CHR25 it is 1:15 for CALEX® Cap and 1:150 for Smart Prep and ScheBo.
Quantum Blue® – General Issues
Each kit box contains a lot-specific RFID card, giving you lot-specific calibration curve data as no calibrators are within the kit.
Consult the troubleshooting chapter in the Quantum Blue® reader manual or consult our support.
Try installing the appropriate driver found on the CD-ROM delivered with the Quantum Blue® reader.
Cellular Allergy – General Issues
Interactions are possible with systemically administered anti-inflammatory drugs. However, no impact of anti-histamines has been shown. Nevertheless, we recommend to stop administration of such drugs according to our instruction for use.
Blood samples for the assay have to be taken before any in vivo tests such as provocation test or skin test.
Blood samples should not be centrifuged nor frozen before the assay.
The anti-Fcepsilon receptor I antibody serves as positive control for IgE-dependent basophil degranulation. The fMLP is used as IgE-independent control for cell degranulation.
Non-responders are characterized by a low reactivity to anti-Fcepsilon receptor I or fMLP (<10% CD63 positive cells). 6.1% out of n=98 samples were non-responders to Fcepsilon receptor I and 4.9% out of n=61 were non-responders to fMLP in an internal study.
Cellular Allergy – Flow CAST®
Any cytometer that has a 488 nm argon laser can excite the fluorophores (FITC and PE) used in this test.
The venipuncture tubes have to be filled to the dedicated volume with blood. Insufficiently filled tubes (< 50%) lead to higher EDTA concentration in the sample and may lead to false negative results.
Blood samples should be used within 48 hours for allergens such as insect venoms, environmental, occupational, inhalants and food. Samples using drug allergens and food additives should be analysed within 24 hours.
It has low impact. For 8 samples that were double stained using anti-CCR3 and anti-CD3 antibody, the mean % of CD3 positive cells within the population of double-stained cells was 3.9%.
Basophils are very sensitive cells. Avoid shear stress. Always use deionized, double distilled water that is ultra-filtrated. Furthermore, make sure that no contamination occurs during the assay (e.g. through dust, pollen, etc).
Check whether assay procedure has been followed according to the IFU (especially insufficient cell lysis may interfere since contamination of erythrocytes may occur), check instrument settings and adjust voltage.
Cellular Allergy – CAST® ELISA
Perform the cell stimulation within 24 hours after blood collection. Store blood samples if necessary refrigerated at 2-8°C.
Use only EDTA whole blood and collect sufficient into EDTA venipuncture tubes. 200 µl of whole blood are needed per reaction tube. Calculate the amount of blood needed. For further information see also IFU on page 4.
Cellular Allergy – CAST® Allergens
All BÜHLMANN allergens are CE-marked in combination with the CAST® assays.
CAST® Allergens can be stored unopened at – 20°C until expiration date. Reconstituted allergens should be used immediately. Reconstituted bee venom and wasp venom allergens are stable for 1 month at -20°C.
CAST® allergens are partly recombinant and partly from native source. Contact your local distributor for more information.
Allergens have to be ordered separately.
Clinical Chemistry – ACE kinetic
Lipemic sera may be used up to a serum concentration of 250 mg/dl.
Icteric sera may be used up to a serum concentration of ≤ 20 mg/dl
No, hemolytic samples cannot be used.
One unit of ACE activity is defined as the amount of enzyme required for release one µmol of hipuric acid per minute and per liter of serum at 37°C as determined by the colorimetric assay.
The functional sensitivity is roughly 12 U/l.
No, the intended use of the assay is for serum only.
BÜHLMANN offers settings for various clinical analyzers from all major manufacturers. Contact your local distributor for more information.
Clinical Chemistry – ACE high sensitive
One unit of ACE activity is defined as the amount of enzyme required for release one µmol of hipuric acid per minute and per liter of serum at 37°C as determined by the colorimetric assay.
CSF samples can be stored for 24 hours at 2-8°C or at -20°C for longer time periods.
The intended use of the high sensitivity assay for ACE is to evaluate ACE levels in cerebrospinal fluid (CSF). The functional sensitivity is roughly 1.0 U/l.
No, CSF samples have to be used undiluted.
BÜHLMANN offers settings for various chemistry analyzers from all major manufacturers. Contact your local distributor for more information.
Chemistry – GHB
No interference is detected (further details see GHB IFU page 4).
No interference is detected (further details see GHB IFU page 4).
No interference is detected (further details see GHB IFU page 4).
Up to 3‰ the measured GHB concentration is below 10 mg/L. 1 g/L Ethanol raises the GHB value by 3 mg/L.
Neuroimmunology
It reflects the dynamic properties of peripheral neuropathies. Patients within a grey zone should be considered for re-testing and further clinical investigations.
Our highly specific anti-ganglioside antibodies react with low affinity and are therefore performing best at lower temperatures.
The GanglioCombi Mag™ ELISA offers the possibility to screen in a first step using the IgM/IgG-mix, while in a second step the presence of antibodies using the specific IgM or IgG enzyme labels is confirmed.